Indian drugmakers are responding with geographic diversification, supply-chain resilience and acquisition of US assets to ...

Nifty Pharma dropped 0.66% at intraday as it underperformed benchmark Nifty 50 which dropped 0.46% at intraday.

Here is the complete list of stocks that will remain in focus today as they trade ex-dividend on August 8, along with their ...

ABB India Ltd., Aurobindo Pharma Ltd., Paras Defence and Space Technologies Ltd. and Quess Corp are some of the other ...

Several companies like Ceat and Indian Oil will trade ex-dividend from August 8, 2025. These companies recently announced ...

Aurobindo Pharma USA will acquire Lannett from Lannett Seller Holdco for $250 million on a cash-free, debt-free basis.

In a market overshadowed by US tariff threats and a tumbling rupee, cautious trading is essential. This article outlines the ...

Elara Capital observes that Aurobindo Pharma has 14 biosimilars in the pipeline. The company has also filed 3 biosimilars for ...

Motilal Oswal is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 1300 in its ...

Indian pharmaceutical stocks traded under pressure on Wednesday after US President Donald Trump said he would sharply raise tariffs on imported medicines. In an interview with CNBC, he said he would ...